Glucagon-like peptide 1 receptor agonists (GLP-1 RA) are attractive options, since they effectively reduce weight and improve blood glucose, without increasing the risk of hypoglycemia
Chronic suppression of food intake could lead to muscle loss, potentially resulting in sarcopenia, they wrote, adding that combination strategies, possibly including agents that preserve or increase muscle mass, may help mitigate this effect. The study ran for three weeks, used only male mice and lost two animals from the tirzepatide group before the end
The plan is provider-determined after reviewing your assessment and safety factors
This essential vitamin also promotes brain health and improves mood
Weight loss drugs could help with binge eating disorder 16 July 2026 Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder, in a new review of evidence led by UCL researchers